| Literature DB >> 26389895 |
Takashi Sawamura1, Tatsumi Tanaka2, Hiroyuki Ishige3, Masayuki Iizuka4, Yasutoshi Murayama5, Eigo Otsuji6, Akihiro Ohkubo7, Shun-Ichiro Ogura8, Hideya Yuasa9.
Abstract
An improvement in photodynamic therapy (PDT) efficiency against a human gastric cancer cell line (MKN45) with 5-aminolevulinic acid (ALA) and lanthanide nanoparticles (LNPs) is described. An endogenous photosensitizer, protoporphyrin IX, biosynthesized from ALA and selectively accumulated in cancer cells, is sensitizable by the visible lights emitted from up-conversion LNPs, which can be excited by a near-infrared light. Ten kinds of surface modifications were performed on LNPs, NaYF₄(Sc/Yb/Er) and NaYF₄(Yb/Tm), in an aim to distribute these irradiation light sources near cancer cells. Among these LNPs, only the amino-functionalized LNPs showed affinity to MKN45 and HeLa cancer cells. A PDT assay with MKN45 demonstrated that amino-modified NaYF₄(Sc/Yb/Er) gave rise to a dramatically enhanced PDT effect, reaching almost perfect lethality, whereas NaYF₄(Yb/Tm)-based systems caused little improvement in PDT efficiency. The improvement of PDT effect with the amino-modified NaYF₄(Sc/Yb/Er) is promising for a practical PDT against deep cancer cells that are reachable only by near-infrared lights.Entities:
Keywords: ALA; lanthanide nanoparticle; near-infrared; up-conversion luminescence
Mesh:
Substances:
Year: 2015 PMID: 26389895 PMCID: PMC4613315 DOI: 10.3390/ijms160922415
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Photodynamic therapy with protoporphyrin IX (PPIX) as a photosensitizer. Uptake of 5-aminolevulinic acid (ALA) by a cancer cell leads to the accumulation of PPIX. A visible light (VL) may suffer from low penetrativity, resulting in failure to excite PPIX by epidermal irradiation. Lanthanide nanoparticles (LNP), if delivered near the cancer cell, will successfully excite PPIX by irradiation with high penetrative near-infrared (NIR) light.
Figure 2Absorption spectrum of PPIX. The five-fold expanded spectrum within Q bands region (470–650 nm) is overlaid for visual clarity.
Figure 3Transmission electron microscopy (TEM) images of (a) LNP(Er)AP; (b) LNP(Tm)AP. LNP: lanthanide nanoparticle; A1P: aminopropyl.
Figure 4Up-conversion luminescence spectra (λex 980 nm) of (a) LNP(Er)OA and LNP(Er)AP; (b) LNP(Tm)OA and LNP(Tm)AP. LNP: lanthanide nanoparticle; OA: oleic acid; AP: aminopropyl.
Figure 5(a) MKN45 cells incubated with LNP(Er)AP under white light (left) and near-infrared light with 980 nm laser diode (middle) and the superposition of them (right); (b) HeLa cells incubated with LNP(Er)DAB under white light (left) and near-infrared light with 980 nm laser diode (middle) and the superposition of them (right). LNP: lanthanide nanoparticle; AP: aminopropyl; DAB: diaminobutane.
Figure 6(a) The pulse modulation mode of NIR laser irradiation for the photodynamic therapy (PDT) assay: 4- or 5-min on and 2-min off with a pulse width (PW) of 0.2 ms and a pulse delay (PD) of 0.8 ms; (b) MKN45 cell viability by irradiation with a diode laser (976 nm, 62.1 W/cm2). The pulse irradiation for 5 min (Er) or 4 min (Tm) was repeated with 2 min intervals.